HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A).

Abstract
Klebsiella pneumoniae (Kp) a common cause of pneumonia leads to intense lung injury and mortality that are correlated with infective exacerbations. Probiotics are a class of microorganisms that have immunomodulatory effects to benefit health. We investigated whether the probiotic Bifidobacterium longum 5(1A) induces protection in mice against lung infection induced by Kp and the potential involved mechanisms. Kp infection induced secretion of pro-inflammatory cytokines, neutrophil recruitment, significant bacterial load in the lung and 50% lethality. However, treatment with live B. longum 5(1A) induced faster resolution of inflammation associated with an increased production of IL-10, decreased lung damage with significantly reduction of bacterial burden that contributed to rescue 100% of mice from death. We found that these effects could be attributed, at least in part, to activation of the Toll-like receptor (TLR) adapter protein Mal, since B. longum 5(1A) treatment in Mal-deficient infected mice did not show the protection observed in wild type infected mice. Thus, we propose that live B. longum 5(1A) activates TLR-signaling pathway that results in ROS production and protects the host against pneumonia-induced death by finely tuning the inflammatory response and contributing to faster return to lung homeostasis.
AuthorsAngélica T Vieira, Victor M Rocha, Luciana Tavares, Cristiana C Garcia, Mauro M Teixeira, Sérgio C Oliveira, Geovanni D Cassali, Conrado Gamba, Flaviano S Martins, Jacques R Nicoli
JournalMicrobes and infection (Microbes Infect) Vol. 18 Issue 3 Pg. 180-9 (Mar 2016) ISSN: 1769-714X [Electronic] France
PMID26548605 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Topics
  • Animals
  • Bacterial Load
  • Bifidobacterium (immunology)
  • Child
  • Disease Models, Animal
  • Humans
  • Immunomodulation
  • Klebsiella Infections (therapy)
  • Klebsiella pneumoniae (immunology)
  • Mice, Inbred C57BL
  • Pneumonia, Bacterial (therapy)
  • Probiotics (administration & dosage)
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: